Neurobehcet with cerebral aneurysm.

Neurosciences (Riyadh)

Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia. E-mail:

Published: October 2018

Neuro-behcets disease (NBD) is an uncommon, serious presentation of behcets disease (BD) causing long-term morbidity and mortality. Cerebral aneurysms are rare in BD, with only a handful of cases reported worldwide. A 39-year-old female experienced slurring of speech, numbness, and reduced sensation in the left face, arm, and leg 90 minutes prior to presentation. She provided a history of recurrent oral and genital ulcers associated with intermittent joints pain and blurring of vision. erythrocyte sedimentation rate was elevated, but all other autoimmune workup was negative. Neuro-behcets disease was diagnosed. Brain magnetic resonance imaging demonstrated acute right periventricular infarction. Magnetic resonance angiogram revealed M1 segment stenosis and right internal carotid artery saccular aneurysm. Catheter angiography confirmed its presence measuring 4.8 mm X 6.1 mm. She was stabilized after coiling of the aneurysm and was started on medical therapy. Brain imaging should be carried out in young patients with BD presenting with an ischemic event, and intervention may be lifesaving.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015569PMC
http://dx.doi.org/10.17712/nsj.2018.4.20180280DOI Listing

Publication Analysis

Top Keywords

neuro-behcets disease
8
magnetic resonance
8
neurobehcet cerebral
4
cerebral aneurysm
4
aneurysm neuro-behcets
4
disease nbd
4
nbd uncommon
4
uncommon serious
4
serious presentation
4
presentation behcets
4

Similar Publications

To investigate the clinical features and prognosis of neuro-Behçet's syndrome (NBS) in children. The clinical, brain magnetic resonance imaging and laboratory data of 5 children with NBS diagnosed in the Department of Pediatrics, General Hospital of Ningxia Medical University and Department of Rheumatology and Immunology, Children's Hospital Affiliated to Capital Institute of Pediatrics from April 2014 to April 2024 were analyzed retrospectively. The follow-up method was retrospective outpatient or inpatient visit to evaluate the treatment effect of NBS.

View Article and Find Full Text PDF

This case highlights the importance of considering Neuro-Behçet's disease (NBD) in the differential diagnosis of multiple sclerosis (MS), particularly in patients presenting with neurological manifestations, abnormal magnetic resonance imaging (MRI) findings, and systemic symptoms consistent with Behçet's disease (BD).

View Article and Find Full Text PDF

Neuro-Behçet leading to coma: A case report.

Radiol Case Rep

January 2025

Central Radiology Department, Ibn Sina University Hospital Center, Mohamed V University of Rabat, Rabat, Morocco.

Neuro-Behçet disease is often difficult to diagnose due to its complex and severe clinical presentation. This article reports the case of a 35-year-old female patient with a history of Behçet's disease, admitted for a deep coma. Brain MRI performed upon admission revealed extended lesions in the basal ganglia, thalami, and midbrain, along with leptomeningeal contrast enhancement in the temporal region, suggesting meningoencephalitis compatible with parenchymal involvement of neuro-Behçet's disease.

View Article and Find Full Text PDF

Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome.

NEJM Evid

November 2024

Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Centre national de références Maladies Autoimmunes et systémiques rares, National Reference Centre for Rare Autoinflammatory Diseases and Inflammatory Amyloidosis, INSERM, UMR S959, Immunology-Immunopathology-Immunotherapy, Paris.

Article Synopsis
  • A study compared the effectiveness and safety of infliximab and cyclophosphamide as induction therapies for severe Behçet's syndrome involving major vascular or CNS issues.
  • Infliximab showed a higher complete response rate (81%) compared to cyclophosphamide (56%), indicating it may be more effective.
  • Additionally, infliximab had fewer adverse events (29.6%) compared to cyclophosphamide (64%), suggesting it may also be safer for patients.
View Article and Find Full Text PDF
Article Synopsis
  • - Neuro-Behçet's disease (NBD) is a serious complication of Behçet's disease (BD), and a study in Northern Spain aimed to estimate its current incidence from 1999 to 2019 based on 120 patients diagnosed with BD using international criteria.
  • - A total of 96 patients were analyzed, with NBD diagnosed in 24% of them; the average age was 44 years, and genetic testing showed HLA-B51 positivity in about 38% of the cases.
  • - The incidence rate of NBD during the study was found to be 0.13 per 100,000 people-years, with no significant gender differences and a trend towards earlier diagnosis over time,
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!